Search research articles
Contact Us
Filters
Showing results (151-160 of 267) with videos related to
Page
of 27
Sort By:
Studies in Health Technology and Informatics
|
August 8, 2013
Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system
Nassim Douali, Meriem Abdennour, Magali Sasso, et al.
The Lancet. Gastroenterology & Hepatology
|
October 13, 2024
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
Rohit Loomba, Pierre Bedossa, Katharine Grimmer, et al.
Neuro-Oncology
|
February 22, 2014
Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas
Alizée Boin, Anne Couvelard, Christophe Couderc, et al.
Ultrasound in Medicine & Biology
|
July 30, 2016
AdipoScan: A Novel Transient Elastography-Based Tool Used to Non-Invasively Assess Subcutaneous Adipose Tissue Shear Wave Speed in Obesity
Magali Sasso, Yuejun Liu, Judith Aron-Wisnewsky, et al.
Journal of Hepatology
|
January 17, 2012
Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity
Joan Tordjman, Adeline Divoux, Edi Prifti, et al.
JHEP Reports : Innovation in Hepatology
|
November 17, 2021
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
Philippe Garteiser, Laurent Castera, Muriel Coupaye, et al.
Hepatology (Baltimore, Md.)
|
August 31, 2006
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up
Corinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, et al.
Journal of Hepatology
|
February 22, 2023
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)
Stephen A Harrison, Carole Thang, Sébastien Bolze, et al.
Journal of Hepatology
|
March 27, 2026
Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
Jörn M Schattenberg, Pierre Bedossa, Cynthia D Guy, et al.
Journal of Virology
|
March 28, 2014
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C
Emilie Estrabaud, Martine Lapalus, Philippe Broët, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 267) with videos related to
Sort By:
Page
of 27
Studies in Health Technology and Informatics
|
August 8, 2013
Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system
Nassim Douali, Meriem Abdennour, Magali Sasso, et al.
The Lancet. Gastroenterology & Hepatology
|
October 13, 2024
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
Rohit Loomba, Pierre Bedossa, Katharine Grimmer, et al.
Neuro-Oncology
|
February 22, 2014
Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas
Alizée Boin, Anne Couvelard, Christophe Couderc, et al.
Ultrasound in Medicine & Biology
|
July 30, 2016
AdipoScan: A Novel Transient Elastography-Based Tool Used to Non-Invasively Assess Subcutaneous Adipose Tissue Shear Wave Speed in Obesity
Magali Sasso, Yuejun Liu, Judith Aron-Wisnewsky, et al.
Journal of Hepatology
|
January 17, 2012
Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity
Joan Tordjman, Adeline Divoux, Edi Prifti, et al.
JHEP Reports : Innovation in Hepatology
|
November 17, 2021
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
Philippe Garteiser, Laurent Castera, Muriel Coupaye, et al.
Hepatology (Baltimore, Md.)
|
August 31, 2006
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up
Corinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, et al.
Journal of Hepatology
|
February 22, 2023
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)
Stephen A Harrison, Carole Thang, Sébastien Bolze, et al.
Journal of Hepatology
|
March 27, 2026
Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
Jörn M Schattenberg, Pierre Bedossa, Cynthia D Guy, et al.
Journal of Virology
|
March 28, 2014
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C
Emilie Estrabaud, Martine Lapalus, Philippe Broët, et al.
Page
of 27